If not, they will order new tests before moving forward with a prescription
Holistic care management Although much of the current cultural discourse about GLP-1s is related to how the medications are used to manage weight, the fact of the matter is most patients (the KFF survey said around six in 10) are taking them to manage diabetes and heart disease
Important Note: The telehealth weight loss industry, particularly platforms offering compounded GLP-1 medications, has been under increased regulatory scrutiny in recent years
This is why patients are paying attention
The proposed rule would permanently exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list, meaning that even a future shortage would not reopen large-scale compounding through outsourcing facilities
New Annals of Oncology target-trial emulation in obese, nondiabetic adults suggests a signal worth watching